Recombinant DNA Technology Market Is Anticipated To Reach $844.6 Billion By 2025: Grand View Research, Inc.
The global recombinant DNA technology market is expected to reach USD 844.6 billion by 2025, according to a new report by Grand View Research, Inc. Success of genetically engineered human insulin in diabetes treatment has triggered the development of many other recombinant therapeutics and drugs. This has translated to the huge success of Recombinant DNA (rDNA) technology. This technology has offered significant prospects for elucidating the gap between disease and its effective treatment. Widespread successful application of this technique in veterinary product development, genetically modified crop development, bio pesticides & biofuel production, and gene therapy, are expected to spur the adoption of this technology throughout the forecast period. Use of Genetically Modified (GM) products, such as GM animals, developed using rDNA method are found to be indispensable to accelerate medical research. Furthermore, more than 3000 scientific studies have been carr...